JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3001
PUT
Vulcan Materials
VMC
$31.5B
| $4.53M | ﹤0.01% |
18,200
| – | – |
2024 Q1
1 quarter
|
|
3002
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$877M
| $4.52M | ﹤0.01% |
105,316
-12,619
| -11% | -$540K |
2023 Q2
4 quarters
|
|
3003
Brinker International
EAT
$8.46B
| $4.52M | ﹤0.01% |
62,450
-40,291
| -39% | -$2.4M |
2013 Q2
44 quarters
|
|
3004
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.3B
| $4.52M | ﹤0.01% |
88,085
+20,820
| +31% | +$1.07M |
2022 Q1
9 quarters
|
|
3005
Liberty Global Class C
LBTYK
$2.98B
| $4.52M | ﹤0.01% |
260,590
-194,601
| -43% | -$3.39M |
2013 Q2
44 quarters
|
|
|
JOYY
3006
JOYY Inc
JOYY
$3.88B
| $4.5M | ﹤0.01% |
149,717
+129,687
| +647% | +$4.14M |
2015 Q4
34 quarters
|
|
3007
iShares New York Muni Bond ETF
NYF
$1.46B
| $4.5M | ﹤0.01% |
84,209
+80,302
| +2,055% | +$4.28M |
2015 Q4
34 quarters
|
|
|
HPP
3008
Hudson Pacific Properties
HPP
$623M
| $4.49M | ﹤0.01% |
133,437
-79,356
| -37% | -$2.99M |
2014 Q4
38 quarters
|
|
|
CALY
3009
Callaway Golf Company
CALY
$2.58B
| $4.47M | ﹤0.01% |
292,349
-207,270
| -41% | -$3.24M |
2014 Q4
38 quarters
|
|
3010
BridgeBio Pharma
BBIO
$13.1B
| $4.46M | ﹤0.01% |
176,079
-190,574
| -52% | -$5.21M |
2019 Q2
20 quarters
|
|
3011
CALL
Tapestry
TPR
$23.6B
| $4.46M | ﹤0.01% |
104,200
-246,600
| -70% | -$10.3M |
2024 Q1
1 quarter
|
|
3012
Dorman Products
DORM
$3.65B
| $4.46M | ﹤0.01% |
48,728
-18,704
| -28% | -$1.71M |
2015 Q4
34 quarters
|
|
3013
PUT
Madrigal Pharmaceuticals
MDGL
$11.5B
| $4.45M | ﹤0.01% |
15,900
+15,000
| +1,667% | +$3.57M |
2024 Q1
1 quarter
|
|
3014
PUT
Alcon
ALC
$30.8B
| $4.45M | ﹤0.01% |
+50,000
| New | +$4.27M |
2024 Q2
0 quarters
|
|
3015
Teladoc Health
TDOC
$1B
| $4.45M | ﹤0.01% |
455,329
+283,477
| +165% | +$3.46M |
2015 Q3
35 quarters
|
|
3016
TransAlta
TAC
$3.91B
| $4.45M | ﹤0.01% |
628,913
-87,874
| -12% | -$602K |
2014 Q3
39 quarters
|
|
3017
CALL
Abercrombie & Fitch
ANF
$5.77B
| $4.45M | ﹤0.01% |
25,000
-25,000
| -50% | -$3.62M |
2023 Q4
2 quarters
|
|
3018
Renasant Corp
RNST
$3.65B
| $4.44M | ﹤0.01% |
145,403
-59,856
| -29% | -$1.78M |
2016 Q4
30 quarters
|
|
3019
StoneCo
STNE
$2.2B
| $4.43M | ﹤0.01% |
369,862
-8,307
| -2% | -$123K |
2019 Q3
19 quarters
|
|
3020
CALL
Cloudflare
NET
$124B
| $4.43M | ﹤0.01% |
53,500
+2,800
| +6% | +$226K |
2023 Q2
4 quarters
|
|
3021
Emergent Biosolutions
EBS
$325M
| $4.43M | ﹤0.01% |
649,502
+375,962
| +137% | +$1.62M |
2014 Q1
41 quarters
|
|
3022
National Healthcare
NHC
$3.57B
| $4.41M | ﹤0.01% |
40,654
-746
| -2% | -$72.7K |
2016 Q3
31 quarters
|
|
3023
CALL
Biogen
BIIB
$32.5B
| $4.4M | ﹤0.01% |
19,000
| – | – |
2021 Q3
11 quarters
|
|
3024
CALL
Zoetis
ZTS
$28.8B
| $4.4M | ﹤0.01% |
25,400
-78,200
| -75% | -$13M |
2024 Q1
1 quarter
|
|
3025
Archrock
AROC
$5.32B
| $4.39M | ﹤0.01% |
217,142
-204,891
| -49% | -$4.06M |
2013 Q2
44 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.